EP 3194616 B1 20200729 - MRNA AND/OR PROTEIN OF ERCC1 ISOFORM 3 FOR USE IN DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT AND METHOD FOR DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT USING SAID MRNA AND/OR PROTEIN
Title (en)
MRNA AND/OR PROTEIN OF ERCC1 ISOFORM 3 FOR USE IN DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT AND METHOD FOR DIAGNOSING A RESISTANCE AGAINST A THERAPEUTIC AGENT USING SAID MRNA AND/OR PROTEIN
Title (de)
MRNA UND/ODER PROTEIN VON ERCC1-ISOFORM 3 ZUR VERWENDUNG BEI DER DIAGNOSE EINER RESISTENZ GEGEN EIN THERAPEUTIKUM UND VERFAHREN ZUR DIAGNOSE EINER RESISTENZ GEGEN EIN THERAPEUTIKUM UNTER VERWENDUNG DES BESAGTEN MRNA UND/ODER PROTEINS
Title (fr)
MRNA ET/OU PROTÉINE DE ERCC1 ISOFORME 3 DESTINÉS À ÊTRE UTILISÉS POUR DIAGNOSTIQUER UNE RÉSISTANCE CONTRE UN AGENT THÉRAPEUTIQUE ET PROCÉDÉ PERMETTANT DE DIAGNOSTIQUER UNE RÉSISTANCE CONTRE UNE MRNA UTILISANT LEDIT AGENT THÉRAPEUTIQUE ET/OU DE PROTÉINE
Publication
Application
Priority
- EP 14185247 A 20140918
- EP 2015071170 W 20150916
Abstract (en)
[origin: WO2016042009A1] The detection of circulating tumor cells (CTC) is widely accepted as an independent prognostic tool in solid cancers as well in primary disease and metastatic disease. Therapy failure during treatment of said diseases was indicated by CTC not disappearing in the course of a given therapy. However, it turned out that such prognostic information alone is of limited usefulness since it does not help in predicting therapeutic success of certain therapeutic agents before a therapy is even started.
IPC 8 full level
C12Q 1/6886 (2018.01); C12Q 1/6804 (2018.01)
CPC (source: EP US)
C12Q 1/6804 (2013.01 - EP US); C12Q 1/6886 (2013.01 - EP US); C12Q 2600/106 (2013.01 - EP US); C12Q 2600/156 (2013.01 - US); C12Q 2600/158 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016042009 A1 20160324; EP 3194616 A1 20170726; EP 3194616 B1 20200729; JP 2017529074 A 20171005; JP 2021019612 A 20210218; JP 7057668 B2 20220420; US 2017233826 A1 20170817
DOCDB simple family (application)
EP 2015071170 W 20150916; EP 15766784 A 20150916; JP 2017513004 A 20150916; JP 2020168483 A 20201005; US 201515511837 A 20150916